专利号:WO-2025128848-A1 优先权日:2023-12-12 标题:Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use 发明人:HOUZE JONATHAN B; PANDYA BHAUMIK 权利人:VIGIL NEUROSCIENCE INC 摘要:The present disclosure provides compounds of Formula (I), useful for the activation of Triggering Receptor Expressed on Myeloid Cells 2 ('TREM2'). This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a neurodegenerative disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula (I).
专利号:US-7858809-B2 优先权日:2004-04-12 标题 :Process for production of pyrazole-fused ring derivatives 发明人:NEGI SHIGETO; SHIMIZU TOSHIKAZU; KURODA HIROSHI; SHIMOMURA NAOYUKI; SASHO MANABU; HOSHINO YORIHISA; KUBOTO MANABU 权利人:EISAI R&D MAN CO LTD 摘要:Intermediates useful for the synthesis of pyrazole-fused ring derivatives, such as 7-phenylpyrazolo [1,5-a]pyridine derivatives, and method for producing the same. Method for producing compound represented by the general formula (II), wherein Z 1 and Z 2 each independently represents a methine group or a nitrogen atom; R l represents an ethyl group or the like; R 5 represents a hydrogen atom or the like; R 2 and R 3 each independently represents a C 1-6 alkyl group or the like, salts thereof, or solvates of both, comprising the step of: reacting a compound represented by the general formula (I), wherein Z 1 , Z 2 , R 5 , R 1 , R 2 and R 3 each has the same definition as described above, with an organometallic reagent; and then reacting the resulting product with pentafluoroiodobenzene.
专利号:CN-102993144-B 优先权日:2012-12-07 标 题 :One-pot synthesis of 4-aminotetrahydropyran
专利号:CN-102993144-A 优先权日:2012-12-07 标 题 :One-pot synthesis of 4-aminotetrahydropyran
专利号:WO-2005106495-A1 优先权日:2004-05-04 标题 :Procollagen ii biomarkers and methods 发明人:ABRAMS MARK ALLAN; AGGARWAL POONAM PEREIRA; DUFIELD DAWN RENE; MATHEWS RODNEY W; NEMIROVSKIY OLGA VLADIMIROVNA; SUNYER TERESA 权利人:PHARMACIA & UPJOHN CO LLC; ABRAMS MARK ALLAN; AGGARWAL POONAM PEREIRA; DUFIELD DAWN RENE; MATHEWS RODNEY W; NEMIROVSKIY OLGA VLADIMIROVNA; SUNYER TERESA 摘要:A method of prediction disease progression in a disorder characterized by the uncoupling of collagen type II synthesis and degradation is disclosed. There is further disclosed a method of detecting specific procollagen fragments associated with osteoarthritis. The fragments are derived from procollagen type IIB (PIIBNP). A method for determining the efficacy of an agent or drug intended to decrease or inhibit a collagenase enzyme is disclosed.